Verify J codes and units of service, prepare for more MUEs after OIG report

Why This Topic Matters

Incorrect drug code reporting and unit entry can lead to overpayments, denials, and recoupment activity. The article is relevant to organizations that submit injectable Part B drug claims and need to understand current compliance attention around Medicare review and coding accuracy.

Article Sections

1. Overview of the OIG report and Medicare payment concerns

   Introduces the report findings and the broader concern about outpatient drug claim accuracy under Medicare Part B. Explains why injectable drug billing is receiving increased attention.

2. Expected tightening of drug unit controls and MUE review

   Discusses anticipated changes in claim review and the role of medically unlikely edits in drug billing oversight. Summarizes the article’s discussion of how Medicare evaluates units of service on claims.

3. Superbill and charge document preparation

   Covers practice-level documentation and workflow considerations for supporting drug billing. Addresses how charge capture materials are used to help reduce reporting errors.

4. Drug code updates and crosswalk verification

   Describes the use of updated drug coding references and crosswalk tools to confirm reporting accuracy. Notes the article’s focus on code replacement activity and claim validation resources.

5. OIG findings, contractor requirements, and reporting resources

   Summarizes the article’s discussion of related audit findings, contractor reporting expectations, and external reference materials. Includes the broader context for Medicare drug claim review and verification.